Davis J M, Comaty J
Illinois State Psychiatric Institute.
Encephale. 1988 Sep;14 Spec No:257-61.
While the therapeutic value of neuroleptics in the treatment of schizophrenia and psychoses is universally recognized, the risk of tardive dyskinesia linked to the use of these drugs raises ethical and legal problems for the physician. The authors discuss the basic principles linked to these legal aspects of the question: inappropriate indication of neuroleptic treatment, inadequate treatment monitoring, error in diagnosis of tardive dyskinesia and misconduct with regard to informed consent. The various aspects are illustrated by specific cases.
虽然抗精神病药物在治疗精神分裂症和精神病方面的治疗价值已得到普遍认可，但与使用这些药物相关的迟发性运动障碍风险给医生带来了伦理和法律问题。作者讨论了与该问题这些法律方面相关的基本原则：抗精神病药物治疗的不当指征、治疗监测不足、迟发性运动障碍的误诊以及在知情同意方面的不当行为。通过具体案例说明了各个方面。
